115 related articles for article (PubMed ID: 38215083)
1. Discovering peptide inhibitors of thrombin as a strategy for anticoagulation.
Zhen S; Wang G; Li X; Yang J; Yu J; Wang Y
Medicine (Baltimore); 2024 Jan; 103(2):e36849. PubMed ID: 38215083
[TBL] [Abstract][Full Text] [Related]
2. A novel targeted multi-functional fusion protein possesses inhibitory activities against bacteria, thrombin and platelet aggregation.
Gao J; Hu Z; Zhao Z; Liu G; Ren Y; Chen G
Protein J; 2011 Dec; 30(8):521-8. PubMed ID: 21959792
[TBL] [Abstract][Full Text] [Related]
3. Anti-thrombotic Effects Mediated by a Novel Dual-Target Peptide Inhibiting Both Platelet Aggregation and Thrombin Activity without Causing Bleeding.
Yu J; Wang T; Zhang X; Chen Q; Hu Y; Liang Q; Shi Y; Wang Y; Zhang Y; Yu M; Zhao B
Thromb Haemost; 2024 Feb; 124(2):108-121. PubMed ID: 37657484
[TBL] [Abstract][Full Text] [Related]
4. Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex.
Bradford HN; Dela Cadena RA; Kunapuli SP; Dong JF; Löpez JA; Colman RW
Blood; 1997 Aug; 90(4):1508-15. PubMed ID: 9269768
[TBL] [Abstract][Full Text] [Related]
5. The in vitro effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M
Acta Pol Pharm; 2009; 66(3):235-42. PubMed ID: 19645323
[TBL] [Abstract][Full Text] [Related]
6. Thrombin-induced platelet aggregation -effect of dabigatran using automated platelet aggregometry.
Shimizu M; Natori T; Tsuda K; Yoshida M; Kamada A; Oi K; Ishigaku Y; Oura K; Narumi S; Yamamoto M; Terayama Y
Platelets; 2020; 31(3):360-364. PubMed ID: 31161848
[TBL] [Abstract][Full Text] [Related]
7. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
[TBL] [Abstract][Full Text] [Related]
8. Characterization of in vitro and in vivo platelet responses to thrombin and thrombin receptor-activating peptides in guinea pigs.
Chiu PJ; Tetzloff GG; Foster C; Chintala M; Sybertz EJ
Eur J Pharmacol; 1997 Feb; 321(1):129-35. PubMed ID: 9083795
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis.
André P; LaRocca T; Delaney SM; Lin PH; Vincent D; Sinha U; Conley PB; Phillips DR
Circulation; 2003 Nov; 108(21):2697-703. PubMed ID: 14597584
[TBL] [Abstract][Full Text] [Related]
10. Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time?
Witkowski M; Steffens D; Hassanein A; Witkowski M; Kränkel N; Doerner A; Friebel J; Landmesser U; Rauch U
Thromb Res; 2017 Jan; 149():62-63. PubMed ID: 27907813
[No Abstract] [Full Text] [Related]
11. Design, synthesis and structural exploration of novel fluorinated dabigatran derivatives as direct thrombin inhibitors.
Li ML; Ren YJ; Dong MH; Ren WX
Eur J Med Chem; 2015; 96():122-38. PubMed ID: 25874337
[TBL] [Abstract][Full Text] [Related]
12. First Report of Plant-Derived β-Sitosterol with Antithrombotic, in Vivo Anticoagulant, and Thrombus-Preventing Activities in a Mouse Model.
Gogoi D; Pal A; Chattopadhyay P; Paul S; Deka RC; Mukherjee AK
J Nat Prod; 2018 Nov; 81(11):2521-2530. PubMed ID: 30406661
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of factor Xa-induced platelet aggregation by a selective thrombin inhibitor, argatroban.
Kawai H; Yamamoto T; Hara H; Tamao Y
Thromb Res; 1994 May; 74(3):185-91. PubMed ID: 8042187
[TBL] [Abstract][Full Text] [Related]
14. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
Wong PC; Jiang X
Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316
[TBL] [Abstract][Full Text] [Related]
15. (1R,3S)-THCCA-Asn: To show the discovery of selective inhibitor of thrombin by successfully combining virtual screening and biological assay.
Zhang X; Yang Y; Wang Y; Wu J; Fang Q; Wang Y; Zhao M; Peng S
Eur J Med Chem; 2022 Nov; 242():114681. PubMed ID: 36001936
[TBL] [Abstract][Full Text] [Related]
16. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
Liu JT; Paul W; Emerson M; Cicala C; Page CP
Eur J Pharmacol; 1994 Oct; 264(2):183-90. PubMed ID: 7851481
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
18. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
Yamamoto J; Inoue N; Otsui K; Ishii H; Gorog DA
Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
[TBL] [Abstract][Full Text] [Related]
19. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists.
Wielders SJ; Bennaghmouch A; Reutelingsperger CP; Bevers EM; Lindhout T
J Thromb Haemost; 2007 Mar; 5(3):571-6. PubMed ID: 17166251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
